Syndecans are often found to be dysregulated in many types of cancer and their overexpression have been detected in ER-negative breast cancer cells (HER2-positive and triple negative breast cancer) but not in ER-positive as Sdc-1 expression is suppressed by ER. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.